Lv2
150 积分 2024-10-28 加入
Industry Perspective on First‐in‐Human and Clinical Pharmacology Strategies to Support Clinical Development of T‐Cell Engaging Bispecific Antibodies for Cancer Therapy
16天前
已完结
Three-dimensional cerebral vasculature of the CBA mouse brain: A magnetic resonance imaging and micro computed tomography study
3个月前
已完结
Seven-colour multiplex immunochemistry/immunofluorescence and whole slide imaging of frozen sections
3个月前
已完结
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism
4个月前
已完结
Application of new approach methodologies for nonclinical safety assessment of drug candidates
4个月前
已完结
Anti-vascular endothelial growth factor treatment potentiates immune checkpoint blockade through a BAFF- and IL-12-dependent reprogramming of the TME
5个月前
已完结
Overall survival assessment in cancer drug trials: a luxury or a necessity?
5个月前
已完结
Combination of immune checkpoint inhibitors and anti-angiogenic agents: An emerging strategy for cancer therapy
5个月前
已完结
Antiangiogenic–immune-checkpoint inhibitor combinations: lessons from phase III clinical trials
5个月前
已完结
Lack of CD8 + T cell effector differentiation during priming mediates checkpoint blockade resistance in non–small cell lung cancer
6个月前
已完结
皖公网安备34019202002308